Self Management of Oral Anticoagulation With VKA Therapy
Conditions
Keywords
Patient Self-management, Acenocoumarol, Warfarin
Brief summary
ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)
Interventions
Trained patients check weekly the INR using a portable coagulometer an decide by themselves the dosis of VKA
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adult patients (older than 18) under chronic VKA treatment, whom performed patient self-management for any indication of oral anticoagulation. 2. Signed informed consent
Exclusion criteria
1\. Patients younger than 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Thromboembolic events | since 1 of july of 2002 to 30th of june of 2018 | Any documented embolic stroke, peripheral arterial embolism or venous thromboembolism |
| Major hemorrhagic event | since 1 of july of 2002 to 30th of june of 2018 | Any documented bleeding event grade 3 or 5 in the Bleeding Assessment Research Consortium (BARC) scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | since 1 of july of 2002 to 30th of june of 2018 | Death from any cause |
Countries
Spain